4.7 Article

7. Diabetes Technology: Standards of Medical Care in Diabetes-2022

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes

Emi Ushigome et al.

Summary: This study examined the usefulness and safety of remote continuous glucose monitoring in a patient with diabetes and severe interstitial pneumonia caused by COVID-19. Real-time monitoring helped prevent dramatic variations in blood glucose levels and reduced the need for health care workers to enter the isolation room.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction

Moshe Phillip et al.

Summary: The increasing prevalence of diabetes and shortage of health care professionals worldwide have led to the need for new approaches in diabetes care delivery. The use of digital diabetes technologies and telehealth protocols within a digital/virtual clinic has the potential to address these challenges. However, there are still issues to be resolved in advancing these technologies as a standard of care for diabetes management.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Review Endocrinology & Metabolism

Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear

Tiffany Yeh et al.

Summary: As diabetes prevalence rises in the USA, the use of devices like CGMs and insulin pumps has become popular for managing diabetes. Experts agree that carefully selected inpatients can safely benefit from using these technologies to improve glycemic outcomes and reduce hypoglycemia in hospitals. During the COVID-19 pandemic, CGMs were crucial in managing hyperglycemia in some hospitalized patients.

CURRENT DIABETES REPORTS (2021)

Article Medicine, General & Internal

Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study

Carolina Piras de Oliveira et al.

Summary: This study examined the characteristics and perspectives of people with type 1 diabetes who have used half-unit insulin pens compared to those who have never used them. Users of half-unit pens were found to have better control over blood glucose fluctuations and perceived the pens as reducing disease-related anxiety and worry.

CURRENT MEDICAL RESEARCH AND OPINION (2021)

Article Endocrinology & Metabolism

A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes

Linda A. DiMeglio et al.

Summary: The study found that continuous glucose monitoring over a 6-month period in children with type 1 diabetes did not improve time in range, but significantly reduced time spent in hypoglycemia. Family behavioral intervention benefited parental well-being.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic

Shivani Agarwal et al.

Summary: This study conducted real-time continuous glucose monitoring in a group of COVID-19 patients, finding high accuracy and significant reduction in the frequency of point-of-care glucose testing during critical illness.

DIABETES CARE (2021)

Article Cardiac & Cardiovascular Systems

Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy

Rogerio Tavares Ribeiro et al.

Summary: Blinded retrospective continuous glucose monitoring (rCGM) can provide detailed insights into glycaemic profiles for individuals with type 2 diabetes. This study showed that structured introduction of rCGM led to a significant decrease in HbA1c levels and an increase in time spent within the target range for blood glucose over 12 months. Therapeutic changes based on rCGM data were found to be effective in improving clinical outcomes and treatment satisfaction in individuals with poorly controlled type 2 diabetes.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)

Article Pharmacology & Pharmacy

The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes

Heather Ulrich et al.

Summary: This study evaluated the impact of professional CGM on treatment decisions and glucose control in patients with type 2 diabetes, finding that patients using professional CGM had significantly more individuals within their A1c goal range at 3 and 6 months compared to baseline, with a statistically significant difference at both time points.

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2021)

Article Endocrinology & Metabolism

Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept

Georgia M. Davis et al.

Summary: The study shows that a hybrid protocol integrating CGM and POC is helpful for managing critically ill patients with COVID-19 requiring insulin infusion. Sensor accuracy is impacted by mechanical interferences, but the majority of sensor values are within 20% of reference POC glucose levels.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

Intermittently Scanned Continuous Glucose Monitoring Data of Polish Patients from Real-Life Conditions: More Scanning and Better Glycemic Control Compared to Worldwide Data

Jerzy Hohendorff et al.

Summary: The use of Freestyle Libre(R) intermittently scanned continuous glucose monitoring system (isCGMS) is associated with improved glycemic indices and quality of life. Polish isCGMS users perform more scans per day, achieve lower eHbA1c, spend more time in range, and less time above range compared to international data. Results suggest that increasing scan rate frequency leads to improved glycemic metrics, with Polish users achieving better outcomes compared to the global average even with similar scanning frequency.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls

David Nathanson et al.

Summary: In type 1 diabetes patients, the use of flash glucose monitoring was associated with significant improvement in glycemic control over a two-year period, especially in those with higher baseline HbA(1c) levels. Patients using FM also experienced lower rates of severe hypoglycemic events compared to those using conventional self-monitoring of blood glucose.

DIABETOLOGIA (2021)

Article Endocrinology & Metabolism

Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting With Continuous Glucose Monitoring: FUTURE-PEAK

Ben Broos et al.

Summary: The study found that diabetes knowledge and health literacy impact glycemic control, with higher diabetes knowledge and health literacy scores associated with improved glycemic control.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Review Endocrinology & Metabolism

The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study

Tom Elliott et al.

Summary: This study aimed to evaluate the impact of Flash glucose monitoring on glucose control in type 2 diabetes patients, finding a significant decrease in HbA1c in patients using basal insulin after using the device, with improvements not significantly associated with age, BMI, insulin use duration, or sex.

DIABETES & VASCULAR DISEASE RESEARCH (2021)

Article Endocrinology & Metabolism

Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters

Annel Lameijer et al.

Summary: The study among Dutch FLASH users suggests that higher scan rates are associated with improved glycemic control. Increasing scan rates lead to more time spent in the target range, less time in hyperglycemia, and a lower standard deviation of glucose.

DIABETES RESEARCH AND CLINICAL PRACTICE (2021)

Article Medicine, General & Internal

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin A Randomized Clinical Trial

Thomas Martens et al.

Summary: Continuous glucose monitoring (CGM) was more effective in reducing HbA1c levels at 8 months compared to blood glucose meter (BGM) monitoring in adults with poorly controlled type 2 diabetes treated with basal insulin without prandial insulin. Participants using CGM also showed better time in target glucose range and lower mean glucose values.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes

Andrew J. Karter et al.

Summary: In this retrospective cohort study, insulin-treated patients with diabetes who were selected by physicians for real-time continuous glucose monitoring showed significant improvements in HbA1c and reductions in emergency department visits and hospitalizations for hypoglycemia compared to noninitiators, but there were no significant changes in emergency department visits or hospitalizations for hyperglycemia or for any reason.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial

Margaretha M. Visser et al.

Summary: In adults with type 1 diabetes, switching from isCGM to rtCGM significantly improved time in range after 6 months of treatment, suggesting that clinicians should consider using rtCGM to enhance the health and quality of life of people with type 1 diabetes.

LANCET (2021)

Article Endocrinology & Metabolism

Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial

Rafael Vaz Machry et al.

Summary: The study compared the use of pens and syringes for insulin application in elderly patients with type 2 diabetes. The results showed a more significant reduction in HbA1c in the pen group during the 24-week follow-up period. There were no significant differences between the two groups in treatment adherence, hypoglycemia occurrence, need for treatment adjustment, and impact on quality of life.

DIABETOLOGY & METABOLIC SYNDROME (2021)

Article Endocrinology & Metabolism

Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial

David A. Price et al.

Summary: In this pilot study, limited episodic real-time continuous glucose monitoring (rtCGM) use in individuals failing multiple non-insulin therapies resulted in modest, short-term glycemic benefits. However, these benefits were not sustained in the long run.

DIABETES THERAPY (2021)

Article Endocrinology & Metabolism

Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus

Rachel S. Rigo et al.

Summary: This study found that skin complications related to CGM and CSII devices are common in pediatric patients with type 1 diabetes, often leading to interruptions or discontinuation of device use. Further research is needed to elucidate the causes of these reactions and determine optimal prevention methods.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)

Article Endocrinology & Metabolism

Skin Reaction Report Form: Development and Design of a Standardized Report Form for Skin Reactions Due to Medical Devices for Diabetes Management

Guido Freckmann et al.

Summary: Skin reactions caused by medical devices for diabetes management have become a common issue, but there is a lack of standardized documentation in scientific literature and clinical practice. The development of a detailed report form may help differentiate and evaluate these skin reactions more effectively.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)

Article Endocrinology & Metabolism

Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care

Gregg D. Simonson et al.

Summary: The study found that using professional CGM in the management of type 2 diabetes, combined with lifestyle counseling and therapy intensification, significantly improved glycemic control, reduced A1C levels, increased time in range, and decreased time in hyperglycemia.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)

Letter Endocrinology & Metabolism

CGM Initiation Soon After Type 1 Diabetes Diagnosis Results in Sustained CGM Use and Wear Time

Priya Prahalad et al.

DIABETES CARE (2020)

Article Endocrinology & Metabolism

Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study

Dorothee Deiss et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2020)

Review Endocrinology & Metabolism

Reviewing US Connected Diabetes Care: The Newest Member of the Team

Brian J. Levine et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2020)

Article Endocrinology & Metabolism

Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia

Timothy M. E. Davis et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2020)

Article Endocrinology & Metabolism

Randomized Controlled Trial of Mobile Closed-Loop Control

Boris Kovatchev et al.

DIABETES CARE (2020)

Article Endocrinology & Metabolism

Efficacy of Insulclock in Patients with Poorly Controlled Type 1 Diabetes Mellitus: A Pilot, Randomized Clinical Trial

Fernando Gomez-Peralta et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2020)

Article Endocrinology & Metabolism

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial

Sue A. Brown et al.

DIABETES CARE (2020)

Article Endocrinology & Metabolism

Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue

Fortunato Lombardo et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2020)

Review Endocrinology & Metabolism

The Do-It-Yourself Artificial Pancreas: A Comprehensive Review

Jothydev Kesavadev et al.

DIABETES THERAPY (2020)

Article Medicine, General & Internal

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes A Randomized Clinical Trial

Richard E. Pratley et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes A Randomized Clinical Trial

Lori M. Laffel et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study

Archana R. Sadhu et al.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)

Article Endocrinology & Metabolism

Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline

Rodolfo J. Galindo et al.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)

Article Computer Science, Information Systems

Self-monitoring diabetes with multiple mobile health devices

Ryan J. Shaw et al.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2020)

Article Endocrinology & Metabolism

A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits

Ronald F. Dixon et al.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)

Review Endocrinology & Metabolism

Cutaneous Complications With Continuous or Flash Glucose Monitoring Use: Systematic Review of Trials and Observational Studies

Nurul A. Mohd Asarani et al.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)

Article Endocrinology & Metabolism

Using Digital Health Technology to Prevent and Treat Diabetes

Neal Kaufman et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial

Gregory P. Forlenza et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia

Stacey M. Anderson et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature

Stefan Pleus et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus

Susana R. Patton et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Efficacy of Hybrid Closed-Loop System in Adults with Type 1 Diabetes and Gastroparesis

Harsahiba Kaur et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System

Rayhan A. Lal et al.

DIABETES CARE (2019)

Article Endocrinology & Metabolism

Real-World Data from the First US Commercial Users of an Implantable Continuous Glucose Sensor

Patricia Sanchez et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Medicine, General & Internal

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

S. A. Brown et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Endocrinology & Metabolism

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes

Gregory P. Forlenza et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Review Endocrinology & Metabolism

Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis

Vasilios Karageorgiou et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2019)

Article Endocrinology & Metabolism

Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations

John (Jack) L. Leahy et al.

JOURNAL OF THE ENDOCRINE SOCIETY (2019)

Article Endocrinology & Metabolism

Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors

Maria Jose Redondo et al.

DIABETES CARE (2018)

Article Endocrinology & Metabolism

Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital

Guillermo E. Umpierrez et al.

DIABETES CARE (2018)

Article Endocrinology & Metabolism

Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors

David C. Klonoff et al.

DIABETES CARE (2018)

Article Endocrinology & Metabolism

Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch

Michael P. Stone et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Article Endocrinology & Metabolism

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes

Bruce A. Buckingham et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Review Endocrinology & Metabolism

App-Based Insulin Calculators: Current and Future State

Leslie Eiland et al.

CURRENT DIABETES REPORTS (2018)

Article Endocrinology & Metabolism

In-Clinic Evaluation of the MiniMed 670G System Suspend Before Low Feature in Children with Type 1 Diabetes

Michael A. Wood et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Article Endocrinology & Metabolism

Excellent Glycemic Control Maintained by Open-Source Hybrid Closed-Loop AndroidAPS During and After Sustained Physical Activity

Lenka Petruzelkova et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Review Endocrinology & Metabolism

A Review of Blood Glucose Monitor Accuracy

Fraya King et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Article Medicine, General & Internal

Appearance of Do-It-Yourself closed-loop systems to manage type 1 diabetes

Tien-Ming Hng et al.

INTERNAL MEDICINE JOURNAL (2018)

Article Pharmacology & Pharmacy

A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice

Timothy S. Bailey et al.

EXPERT OPINION ON DRUG DELIVERY (2017)

Letter Medicine, General & Internal

FreeStyle Libre: contact irritation versus contact allergy

Olivier Aerts et al.

LANCET (2017)

Article Endocrinology & Metabolism

Managing diabetes in preschool children

Frida Sundberg et al.

PEDIATRIC DIABETES (2017)

Article Endocrinology & Metabolism

International Consensus on Use of Continuous Glucose Monitoring

Thomas Danne et al.

DIABETES CARE (2017)

Article Endocrinology & Metabolism

Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers

Persis V. Commissariat et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2017)

Letter Medicine, General & Internal

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

Richard M. Bergenstal et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Medicine, General & Internal

New Insulin Delivery Recommendations

Anders H. Frid et al.

MAYO CLINIC PROCEEDINGS (2016)

Article Health Care Sciences & Services

Evidence-Based mHealth Chronic Disease Mobile App Intervention Design: Development of a Framework

Calvin C. Wilhide et al.

JMIR RESEARCH PROTOCOLS (2016)

Article Medicine, General & Internal

Smartphone apps for calculating insulin dose: a systematic assessment

Kit Huckvale et al.

BMC MEDICINE (2015)

Article Endocrinology & Metabolism

Translating the Diabetes Prevention Program into an Online Social Network Validation against CDC Standards

S. Cameron Sepah et al.

DIABETES EDUCATOR (2014)

Review Endocrinology & Metabolism

Treat-to-target trials: uses, interpretation and review of concepts

A. J. Garber

DIABETES OBESITY & METABOLISM (2014)

Article Endocrinology & Metabolism

Insulin Pump-Associated Adverse Events in Children and Adolescents-A Prospective Study

Benjamin J. Wheeler et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2014)

Article Endocrinology & Metabolism

Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents

Katharine D. Barnard et al.

BMJ OPEN DIABETES RESEARCH & CARE (2014)

Article Medicine, General & Internal

Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials

Carl V. Asche et al.

CURRENT MEDICAL RESEARCH AND OPINION (2013)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring Pilot in Low-Income Type 1 Diabetes Patients

Paola A. Sequeira et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2013)

Editorial Material Medicine, General & Internal

Meta-analysis: Self-monitoring in non-insulin-treated type 2 diabetes improved HbA1c by 0.25%

Laura Rees Willett

ANNALS OF INTERNAL MEDICINE (2012)

Article Endocrinology & Metabolism

Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes

Tadej Battelino et al.

DIABETES CARE (2011)

Review Endocrinology & Metabolism

Insulin delivery by injection in children and adolescents with diabetes

Ragnar Hanas et al.

PEDIATRIC DIABETES (2011)

Article Endocrinology & Metabolism

Health Economics and Compliance of Vials/Syringes Versus Pen Devices: A Review of the Evidence

Carl V. Asche et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2010)

Article Endocrinology & Metabolism

Dosing Accuracy of Insulin Pens Versus Conventional Syringes and Vials

Y. M. Luijf et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2010)

Article Endocrinology & Metabolism

The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 Diabetes

Roy W. Beck

DIABETES CARE (2009)

Article Endocrinology & Metabolism

Comparative Device Assessments Humalog KwikPen Compared With Vial and Syringe and FlexPen

Debra A. Ignaut et al.

DIABETES EDUCATOR (2009)

Article Endocrinology & Metabolism

Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes

H. J. Yoo et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2008)

Article Medicine, General & Internal

Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Endocrinology & Metabolism

Insulin pump therapy from the time of diagnosis of type 1 diabetes

Neesha Ramchandani et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2006)

Letter Endocrinology & Metabolism

Lipohypertrophy in young patients with type 1 diabetes

O Kordonouri et al.

DIABETES CARE (2002)